RATIONALE: Melanin-concentrating hormone (MCH) is involved in regulation of appetitive behaviors as well as emotional reactivity and reward, behavioral domains relevant to alcohol addiction. MATERIALS AND METHODS: We evaluated the effects of the non-peptide MCH1 receptor antagonist, GW803430 [6-(4-chloro-phenyl)-3-[3-methoxy-4-(2-pyrrolidin-1-yl-ethoxy)-phenyl]-3H-thieno[3,2-d]pyrimidin-4-one; 3-30 mg/kg, i.p.] on alcohol-related behaviors in Wistar rats. RESULTS: Ex vivo binding experiments demonstrated that the GW803430 dose range used resulted in high central MCH1 receptor occupancy. Alcohol self-administration was dose-dependently and potently suppressed, by approximately 80% at the highest dose. Reinstatement of alcohol-seeking induced by alcohol-associated cues was essentially eliminated. In contrast, reinstatement induced by footshock stress was not significantly altered. Taste preference for a quinine/saccharin solution, locomotor activity, and alcohol elimination were unaffected. CONCLUSION: Together, these observations support a specific involvement of the MCH system in mediating alcohol reward and cue-induced relapse to alcohol seeking. MCH1-R antagonism may constitute an attractive treatment target for alcohol use disorders.
RATIONALE: Melanin-concentrating hormone (MCH) is involved in regulation of appetitive behaviors as well as emotional reactivity and reward, behavioral domains relevant to alcohol addiction. MATERIALS AND METHODS: We evaluated the effects of the non-peptide MCH1 receptor antagonist, GW803430 [6-(4-chloro-phenyl)-3-[3-methoxy-4-(2-pyrrolidin-1-yl-ethoxy)-phenyl]-3H-thieno[3,2-d]pyrimidin-4-one; 3-30 mg/kg, i.p.] on alcohol-related behaviors in Wistar rats. RESULTS: Ex vivo binding experiments demonstrated that the GW803430 dose range used resulted in high central MCH1 receptor occupancy. Alcohol self-administration was dose-dependently and potently suppressed, by approximately 80% at the highest dose. Reinstatement of alcohol-seeking induced by alcohol-associated cues was essentially eliminated. In contrast, reinstatement induced by footshock stress was not significantly altered. Taste preference for a quinine/saccharin solution, locomotor activity, and alcohol elimination were unaffected. CONCLUSION: Together, these observations support a specific involvement of the MCH system in mediating alcohol reward and cue-induced relapse to alcohol seeking. MCH1-R antagonism may constitute an attractive treatment target for alcohol use disorders.
Authors: Céline Morens; Pia Nørregaard; Jean-Marie Receveur; Gertjan van Dijk; Anton J W Scheurink Journal: Brain Res Date: 2005-10-28 Impact factor: 3.252
Authors: Shinjae Chung; F Woodward Hopf; Hiroshi Nagasaki; Chun-Ying Li; James D Belluzzi; Antonello Bonci; Olivier Civelli Journal: Proc Natl Acad Sci U S A Date: 2009-04-02 Impact factor: 11.205
Authors: Elizabeth A Duncan; Joyce E Sorrell; Antoine Adamantidis; Therese Rider; Ronald J Jandacek; Randy J Seeley; Bernard Lakaye; Stephen C Woods Journal: Alcohol Clin Exp Res Date: 2007-06-05 Impact factor: 3.455
Authors: Susmita Chatterjee; Pia Steensland; Jeffrey A Simms; Joan Holgate; Jotham W Coe; Raymond S Hurst; Christopher L Shaffer; John Lowe; Hans Rollema; Selena E Bartlett Journal: Neuropsychopharmacology Date: 2010-11-03 Impact factor: 7.853
Authors: Jesse R Schank; Jenica D Tapocik; Estelle Barbier; Ruslan Damadzic; Robert L Eskay; Hui Sun; Kelly E Rowe; Courtney E King; Mengdi Yao; Meghan E Flanigan; Matthew G Solomon; Camilla Karlsson; Kejun Cheng; Kenner C Rice; Markus Heilig Journal: Biol Psychiatry Date: 2013-02-16 Impact factor: 13.382
Authors: Camilla Karlsson; Faazal Rehman; Ruslan Damadzic; Alison L Atkins; Jesse R Schank; Donald R Gehlert; Pia Steensland; Annika Thorsell; Markus Heilig Journal: Psychopharmacology (Berl) Date: 2016-04-05 Impact factor: 4.530
Authors: Jesse R Schank; Charles L Pickens; Kelly E Rowe; Kejun Cheng; Annika Thorsell; Kenner C Rice; Yavin Shaham; Markus Heilig Journal: Psychopharmacology (Berl) Date: 2011-02-22 Impact factor: 4.530
Authors: Andrea Cippitelli; Gloria Brunori; Kelly A Gaiolini; Nurulain T Zaveri; Lawrence Toll Journal: Neuropharmacology Date: 2015-02-14 Impact factor: 5.250
Authors: Yayi Swain; Peter Muelken; Annika Skansberg; Danielle Lanzdorf; Zachary Haave; Mark G LeSage; Jonathan C Gewirtz; Andrew C Harris Journal: Psychopharmacology (Berl) Date: 2020-05-09 Impact factor: 4.530